Biotech
Biotech Investor Burrill Banned From Securities Industry Under SEC Settlement
|
Biotech investor G. Steven Burrill and his firm Burrill Capital Management will pay $5.785 million in fines and disgorgement and accept a ban from the securities under a settlement of charges that he took money from Burrill Life Sciences Capital Fund III to finance his lifestyle and prop up other struggling businesses.